• OPEN AN ACCOUNT
Indian Indices
Sensex
74,003.82 -777.94
( -1.04%)
Global Indices
Nasdaq
52,442.46 -151.83
(-0.29%)
Dow Jones
7,640.91 -37.07
(-0.48%)
Hang Seng
63,634.18 141.19
(0.22%)
Nikkei 225
10,692.77 42.33
(0.40%)
Forex
USD-INR
95.47 0.03
(0.03%)
EUR-INR
110.72 -0.23
(-0.20%)
GBP-INR
129.12 -0.04
(-0.03%)
JPY-INR
0.62 0.00
(0.29%)

EQUITY - MARKET SCREENER

Aristo Bio-Tech & Lifescience Ltd
Industry :  Pesticides / Agrochemicals - Indian
BSE Code
ISIN Demat
Book Value()
76744
INE082101010
65.3923441
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ARISTO
10.24
73.52
EPS(TTM)
Face Value()
Div & Yield %
10.55
10
0.56
 

Alkem strengthens its dermatology portfolio with launch of Renocia Exo™
Sep 08,2026
Alkem Laboratories announced the launch of Renocia Exo™, a next-generation hair regeneration therapy developed to support the health and vitality of the hair follicle through a comprehensive scientific approach.

Commenting on the launch, Sandeep Singh, Managing Director, Alkem, said, “The science of hair restoration has evolved significantly over the last decade, and so has our understanding of what drives progressive hair thinning. It is influenced by multiple biological processes, including follicular miniaturization, altered cellular signalling, oxidative stress, inflammation, and changes within the follicular microenvironment. This evolving understanding calls for equally evolved therapeutic solutions. With Renocia Exo™, we bring together multiple regenerative technologies to support the biology of the hair follicle in a single daily therapy.”